Sessa Capital IM, L.P.

Position in RNA — Atrium Therapeutics, Inc.

CIK 1595849 NEW YORK, NY

Position in RNA

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$7,372,097

New position

Shares Held

551,391

first reported quarter

Ownership

3.22%

of shares outstanding

% of Portfolio

0.14%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2026

1 quarter on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

Sessa Capital IM, L.P. holds $87,007,647 across 4 Biotechnology names. RNA ranks #4 (8.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	FTRE	Fortrea Holdings Inc.	4,593,550	$43,271,241
2	LXRX	Lexicon Pharmaceuticals, Inc.	17,912,961	$27,944,219
3	SABS	SAB Biotherapeutics, Inc.	2,198,457	$8,420,090
4	RNA	Atrium Therapeutics, Inc. This page	551,391	$7,372,097

1 filing row on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$7,372,097	551,391	—	Shares	Sole	2026-05-15
No filing history on record for this holder in this stock.